5 March 2025 in The American Journal of Tropical Medicine and Hygiene
: West Nile virus (WNV), St. Louis encephalitis virus (SLEV), and Usutu virus (USUV) are zoonotic flaviviruses that cause neuroinvasive disease in humans and are maintained in overlapping avian-mosquito transmission cycles. West Nile virus and SLEV cocirculate in the United States, and WNV and USUV cocirculate in Europe. Cross-reactivity of immune responses against closely related flaviviruses is well documented. In birds, prior infection with WNV provides strong protection against SLEV genotype II and V infection, which may explain the decrease in SLEV circulation in the United States after WNV emergence in 1999. However, in 2015, a new SLEV genotype (III) emerged in the United States, suggesting that WNV immunity in birds may not provide cross-protection against this SLEV genotype. Here, we tested whether prior WNV infection protects birds against infection with SLEV genotype III, as well as USUV. First, we established a house sparrow (Passer domesticus) model of infection for SLEV genotype III. We then inoculated house sparrows with WNV and, 4 weeks later, challenged WNV-immune birds with SLEV genotype III or USUV. All birds were completely protected against secondary challenge, with no viremia detected. Low levels of cross-neutralizing antibodies against SLEV and USUV were found in the blood prior to secondary challenge. However, two naturally WNV-exposed house sparrows did develop SLEV genotype III and USUV viremia after inoculation. These results indicate that experimental WNV infection may protect birds against infection with SLEV genotype III and USUV; however, additional studies to investigate the role of avian immunity in flavivirus emergence are necessary.
31 August 2020 in bioRxiv
Usutu virus (USUV; Flavivirus ), a close phylogenetic and ecological relative of West Nile virus, is a zoonotic virus that can cause neuroinvasive disease in humans. USUV is maintained in an enzootic cycle between Culex mosquitoes and birds. Since the first isolation in 1959 in South Africa, USUV has spread throughout Africa and Europe. Reported human cases have increased over the last few decades, primarily in Europe, with symptoms ranging from mild febrile illness to severe neurological effects. In this study, we investigated whether USUV has become more pathogenic during emergence in Europe. Interferon α/β receptor knockout ( Ifnar1 -/- ) mice were inoculated with recent USUV isolates from Africa and Europe, as well as the historic 1959 South African strain. The three tested African strains and one European strain from Spain caused 100% mortality in inoculated mice, with similar survival times and histopathology in tissues. Unexpectedly, a European strain from the Netherlands caused only 12% mortality and significantly less histopathology in tissues from mice compared to mice inoculated with the other strains. Viremia was highest in mice inoculated with the recent African strains and lowest in mice inoculated with the Netherlands strain. Based on phylogenetics, the USUV isolates from Spain and the Netherlands were derived from separate introductions into Europe, suggesting that disease outcomes may differ for USUV strains circulating in Europe. These results also suggest that while more human USUV disease cases have been reported in Europe recently, circulating African USUV strains are still a potential major health concern. Author Summary: Usutu virus (USUV) is an emerging mosquito-borne virus that causes severe neuroinvasive disease in humans. USUV was first detected in Africa in 1959, and cases of human disease have increased in recent years. Most USUV disease cases are now reported in Europe, where the virus currently circulating. One possibility for the increase in case numbers is that USUV strains have become more pathogenic over time during its spread from Africa into Europe. We compared the pathogenesis of five USUV isolates from Africa and Europe in a mouse model. Three isolates from Africa and one isolate from Europe caused 100% mortality in mice. Surprisingly, one isolate from Netherlands caused only 12% motality. Significantly less histopathology was observed in tissues from mice inoculated with the Netherlands strain compared to mice inoculated with the other four strains. Our results suggest that, even though more human USUV disease cases have been reported in Europe recently, African USUV strains are also highly pathogenic.